These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23621802)

  • 1. Next-generation sequencing of cancer consensus genes in lymphoma.
    Hüllein J; Jethwa A; Stolz T; Blume C; Sellner L; Sill M; Langer C; Jauch A; Paruzynski A; von Kalle C; Schmidt M; Glimm H; Zenz T
    Leuk Lymphoma; 2013 Aug; 54(8):1831-5. PubMed ID: 23621802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond.
    Rosenquist R; Rosenwald A; Du MQ; Gaidano G; Groenen P; Wotherspoon A; Ghia P; Gaulard P; Campo E; Stamatopoulos K;
    Haematologica; 2016 Sep; 101(9):1002-9. PubMed ID: 27582569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma.
    Fontanilles M; Marguet F; Bohers É; Viailly PJ; Dubois S; Bertrand P; Camus V; Mareschal S; Ruminy P; Maingonnat C; Lepretre S; Veresezan EL; Derrey S; Tilly H; Picquenot JM; Laquerrière A; Jardin F
    Oncotarget; 2017 Jul; 8(29):48157-48168. PubMed ID: 28636991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of Disease-Related Genes in Chronic Lymphocytic Leukemia by Multiplex PCR-Based Next Generation Sequencing.
    Vollbrecht C; Mairinger FD; Koitzsch U; Peifer M; Koenig K; Heukamp LC; Crispatzu G; Wilden L; Kreuzer KA; Hallek M; Odenthal M; Herling CD; Buettner R
    PLoS One; 2015; 10(6):e0129544. PubMed ID: 26053404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
    Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
    J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Mutation Analysis of Parkinson's Disease Patients Using Multigene Next-Generation Sequencing Panels.
    Gorostidi A; Martí-Massó JF; Bergareche A; Rodríguez-Oroz MC; López de Munain A; Ruiz-Martínez J
    Mol Diagn Ther; 2016 Oct; 20(5):481-91. PubMed ID: 27294386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare RAS Mutations in Metastatic Colorectal Cancer Detected During Routine RAS Genotyping Using Next Generation Sequencing.
    Harlé A; Filhine-Tresarrieu P; Husson M; Boidot R; Rouyer M; Dubois C; Leroux A; Merlin JL
    Target Oncol; 2016 Jun; 11(3):363-70. PubMed ID: 26661077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of High-Throughput Next-Generation Sequencing for HLA Typing on Buccal Extracted DNA: Results from over 10,000 Donor Recruitment Samples.
    Yin Y; Lan JH; Nguyen D; Valenzuela N; Takemura P; Bolon YT; Springer B; Saito K; Zheng Y; Hague T; Pasztor A; Horvath G; Rigo K; Reed EF; Zhang Q
    PLoS One; 2016; 11(10):e0165810. PubMed ID: 27798706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mutations and their genotype-phenotype correlations in patients with Noonan syndrome, using next-generation sequencing.
    Tafazoli A; Eshraghi P; Pantaleoni F; Vakili R; Moghaddassian M; Ghahraman M; Muto V; Paolacci S; Golyan FF; Abbaszadegan MR
    Adv Med Sci; 2018 Mar; 63(1):87-93. PubMed ID: 28957739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like diffuse large B-cell lymphomas at the time of diagnosis.
    Bohers E; Viailly PJ; Dubois S; Bertrand P; Maingonnat C; Mareschal S; Ruminy P; Picquenot JM; Bastard C; Desmots F; Fest T; Leroy K; Tilly H; Jardin F
    Haematologica; 2015 Jul; 100(7):e280-4. PubMed ID: 25749829
    [No Abstract]   [Full Text] [Related]  

  • 11. PCR Techniques in Next-Generation Sequencing.
    Goswami RS
    Methods Mol Biol; 2016; 1392():143-51. PubMed ID: 26843053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic Mutation Screening Using Archival Formalin-Fixed, Paraffin-Embedded Tissues by Fluidigm Multiplex PCR and Illumina Sequencing.
    Wang M; Escudero-Ibarz L; Moody S; Zeng N; Clipson A; Huang Y; Xue X; Grigoropoulos NF; Barrans S; Worrillow L; Forshew T; Su J; Firth A; Martin H; Jack A; Brugger K; Du MQ
    J Mol Diagn; 2015 Sep; 17(5):521-32. PubMed ID: 26165823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
    Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
    Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
    de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
    PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
    Pécuchet N; Legras A; Laurent-Puig P; Blons H
    Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MPD: multiplex primer design for next-generation targeted sequencing.
    Wingo TS; Kotlar A; Cutler DJ
    BMC Bioinformatics; 2017 Jan; 18(1):14. PubMed ID: 28056760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes.
    Singh RR; Patel KP; Routbort MJ; Reddy NG; Barkoh BA; Handal B; Kanagal-Shamanna R; Greaves WO; Medeiros LJ; Aldape KD; Luthra R
    J Mol Diagn; 2013 Sep; 15(5):607-22. PubMed ID: 23810757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine Clinical Mutation Profiling of Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
    Deeb KK; Hohman CM; Risch NF; Metzger DJ; Starostik P
    Arch Pathol Lab Med; 2015 Jul; 139(7):913-21. PubMed ID: 26125431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MET Exon 14 Alterations and New Resistance Mutations to Tyrosine Kinase Inhibitors: Risk of Inadequate Detection with Current Amplicon-Based NGS Panels.
    Poirot B; Doucet L; Benhenda S; Champ J; Meignin V; Lehmann-Che J
    J Thorac Oncol; 2017 Oct; 12(10):1582-1587. PubMed ID: 28779874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a next-generation-sequencing cancer panel for use in the clinical laboratory.
    Simen BB; Yin L; Goswami CP; Davis KO; Bajaj R; Gong JZ; Peiper SC; Johnson ES; Wang ZX
    Arch Pathol Lab Med; 2015 Apr; 139(4):508-17. PubMed ID: 25356985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.